Literature DB >> 35378915

miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma.

Hao Zhang1, Yan Liu2, Zhihong Xu1, Quan Chen1.   

Abstract

Background: Lung adenocarcinoma (LUAD) accounts for approximately 40% of all lung cancer cases. The tumour microenvironment (TME) and microRNAs affect the occurrence, metastasis, recurrence and treatment of tumours. However, the role of microRNAs in the TME and LUAD still needs to be further investigated.
Methods: RNA-seq and microRNA-seq data of LUAD and NSCLC samples were downloaded from the TCGA and GEO database. The immune and stromal components in the TME and the abundance of tumour-infiltrating immune cells (TICs) were calculated by the ESTIMATE and CIBERSORT algorithms, respectively. The differentially expressed microRNAs (DEMs) between different StromalScore and ImmuneScore groups were screened out by the edgeR package. Bioinformatics analysis was performed to screen out important DEMs and explore their functional effect.
Results: Our results revealed that a low StromalScore, ImmuneScore and ESTIMATEScore led to poor prognosis of LUAD. Then, 62 DEMs were screened out as downregulated in both the high StromalScore and ImmuneScore groups. Among these DEMs, elevated expression levels of miR-873, miR-105-2 and miR-516a-2 significantly shortened the survival time of LUAD patients. Subsequent analysis revealed that the expression levels of miR-873 and miR-105-2 were increased significantly in tumour tissues. The expression patterns of these 2 microRNAs were confirmed by GSE102286, implying the important roles of these 2 microRNAs in LUAD. Further analysis showed that miR-873 and miR-105-2 were mainly involved in immune-related pathways and that high expression levels of miR-873 and miR-105-2 decreased the abundance of monocytes and resting dendritic cells in the TME.
Conclusion: Although further exploration is still needed, our results revealed that miR-873 and miR-105-2 were closely related to the TME and affected the prognosis of LUAD by altering the abundance of TICs.
© 2022 Zhang et al.

Entities:  

Keywords:  GEO; TCGA; lung adenocarcinoma; miR-105-2; miR-873; tumour microenvironment

Year:  2022        PMID: 35378915      PMCID: PMC8976495          DOI: 10.2147/IJGM.S352120

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  40 in total

1.  Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.

Authors:  Yonit Lavin; Soma Kobayashi; Andrew Leader; El-Ad David Amir; Naama Elefant; Camille Bigenwald; Romain Remark; Robert Sweeney; Christian D Becker; Jacob H Levine; Klaus Meinhof; Andrew Chow; Seunghee Kim-Shulze; Andrea Wolf; Chiara Medaglia; Hanjie Li; Julie A Rytlewski; Ryan O Emerson; Alexander Solovyov; Benjamin D Greenbaum; Catherine Sanders; Marissa Vignali; Mary Beth Beasley; Raja Flores; Sacha Gnjatic; Dana Pe'er; Adeeb Rahman; Ido Amit; Miriam Merad
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

Review 2.  miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.

Authors:  Rajesha Rupaimoole; George A Calin; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Discov       Date:  2016-02-10       Impact factor: 39.397

3.  Predicting effective microRNA target sites in mammalian mRNAs.

Authors:  Vikram Agarwal; George W Bell; Jin-Wu Nam; David P Bartel
Journal:  Elife       Date:  2015-08-12       Impact factor: 8.140

Review 4.  Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer.

Authors:  Jiabei He; Ying Hu; Mingming Hu; Baolan Li
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

Review 5.  Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.

Authors:  Emily K Kleczko; Jeff W Kwak; Erin L Schenk; Raphael A Nemenoff
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

6.  Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis.

Authors:  Zhiqiang Wang; Jiru Zhang; Bo Yang; Runsheng Li; Linfang Jin; Zhenjun Wang; Haifeng Yu; Chuanxin Liu; Yong Mao; Qingjun You
Journal:  J Cancer       Date:  2019-10-19       Impact factor: 4.207

7.  Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.

Authors:  Xiaohan Dong; Minghui Chang; Xingguo Song; Shanshan Ding; Li Xie; Xianrang Song
Journal:  Thorac Cancer       Date:  2020-12-28       Impact factor: 3.500

8.  Identification of an immune prognostic 11-gene signature for lung adenocarcinoma.

Authors:  Tao Yang; Lizheng Hao; Renyun Cui; Huanyu Liu; Jian Chen; Jiongjun An; Shuo Qi; Zhong Li
Journal:  PeerJ       Date:  2021-01-20       Impact factor: 2.984

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows.

Authors:  Maria D Paraskevopoulou; Georgios Georgakilas; Nikos Kostoulas; Ioannis S Vlachos; Thanasis Vergoulis; Martin Reczko; Christos Filippidis; Theodore Dalamagas; A G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2013-05-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.